BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1147 related articles for article (PubMed ID: 26653189)

  • 1. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
    Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
    Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
    ; Albert RK; Au DH; Blackford AL; Casaburi R; Cooper JA; Criner GJ; Diaz P; Fuhlbrigge AL; Gay SE; Kanner RE; MacIntyre N; Martinez FJ; Panos RJ; Piantadosi S; Sciurba F; Shade D; Stibolt T; Stoller JK; Wise R; Yusen RD; Tonascia J; Sternberg AL; Bailey W
    N Engl J Med; 2016 Oct; 375(17):1617-1627. PubMed ID: 27783918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
    Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
    Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial of supplemental oxygen versus medical air during exercise training in people with chronic obstructive pulmonary disease: supplemental oxygen in pulmonary rehabilitation trial (SuppORT) (Protocol).
    Alison JA; McKeough ZJ; Jenkins SC; Holland AE; Hill K; Morris NR; Leung RW; Williamson KA; Spencer LM; Hill CJ; Lee AL; Seale H; Cecins N; McDonald CF
    BMC Pulm Med; 2016 Feb; 16():25. PubMed ID: 26846438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.
    Andrianopoulos V; Franssen FM; Peeters JP; Ubachs TJ; Bukari H; Groenen M; Burtin C; Vogiatzis I; Wouters EF; Spruit MA
    Respir Physiol Neurobiol; 2014 Jan; 190():40-6. PubMed ID: 24121092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking.
    Sandland CJ; Morgan MD; Singh SJ
    Respir Med; 2008 Aug; 102(8):1148-52. PubMed ID: 18571914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry.
    Rahaghi FF; Monk R; Ramakrishnan V; Beiko T; Strange C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3193-3199. PubMed ID: 33299307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
    Olfert IM; Malek MH; Eagan TM; Wagner H; Wagner PD
    BMC Pulm Med; 2014 Jun; 14():106. PubMed ID: 24975928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiency.
    Pillai AP; Turner AM; Stockley RA
    Ann Am Thorac Soc; 2014 Jul; 11(6):859-64. PubMed ID: 24950156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.
    Kramer MR; Krivoruk V; Lebzelter J; Liani M; Fink G
    Isr Med Assoc J; 1999 Nov; 1(3):165-8. PubMed ID: 10731326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in managing COPD related to α
    Craig TJ; Henao MP
    Allergy; 2018 Nov; 73(11):2110-2121. PubMed ID: 29984428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
    Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
    Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.